Equity incl. NCI
Balance – as of period end · $M
FY2021
3,861$M
All values (10)
| Period | Value ($M) | Status |
|---|---|---|
| FY2026 | 9,808 | reported |
| FY2025 | 8,935 | reported |
| FY2024 | 8,019 | reported |
| FY2023 | 6,207 | reported |
| FY2022 | 5,780 | reported |
| FY2021 | 3,861 | reported |
| FY2020 | 834 | reported |
| FY2019 | −7 | reported |
| FY2018 | −27 | reported |
| FY2017 | −29 | reported |
1 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: equity_total
More metrics for Zoom
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Sources & calculation
- Value
- $3.9B
- Period
- FY2021, ended Jan 31, 2021 · as of Jan 31, 2021 (balance as of date, not a sum)
- Source
- 10-K, filed Mar 18, 2021 · 0001585521-21-000048
- Location
- us-gaap:StockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $3.9B | Mar 18, 2021 | 10-K 0001585521-21-000048 | reported · confidence 1. · current |